Systemic adjuvant therapy for breast cancer.

Research output: Contribution to journalReview articlepeer-review


The benefits of adjuvant systemic therapy in the treatment of early breast cancer are well established. However, many questions remain regarding the appropriate selection of patients and regimens, duration of treatment, timing or sequencing of treatment as well as the role of high-dose chemotherapy or new active drugs such as paclitaxel. Future answers will only come through continued participation in carefully designed clinical research.

Original languageEnglish (US)
Pages (from-to)48-50
Number of pages3
JournalThe Nebraska medical journal
Issue number3
StatePublished - Mar 1996

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Systemic adjuvant therapy for breast cancer.'. Together they form a unique fingerprint.

Cite this